Literature DB >> 18536738

Pattern recognition receptors and interleukin-8 mediate effects of Gram-positive and Gram-negative bacteria on lung epithelial cell function.

R Sorrentino1, P M de Souza, S Sriskandan, C Duffin, M J Paul-Clark, J A Mitchell.   

Abstract

BACKGROUND AND
PURPOSE: Lung epithelial cells express pattern recognition receptors, which react to bacteria. We have evaluated the effect of Gram-positive and Gram-negative bacteria on interleukin-8 (CXCL8) release from epithelial cells and the integrity of the epithelial barrier. EXPERIMENTAL APPROACH: Primary cultures of human airway epithelial cells and the epithelial cell line A549 were used, and CXCL8 release was measured after exposure to Gram-negative or Gram-positive bacteria. Epithelial barrier function was assessed in monolayer cultures of A549 cells.
RESULTS: Gram-positive bacteria Staphylococcus aureus or Streptococcus pneumoniae, induced release of CXCL8 from human airway epithelial cells. These bacteria also disrupted barrier function in A549 cells, an effect mimicked by CXCL8 and blocked by specific binding antibodies to CXCL8. Gram-negative bacteria Escherichia coli or Pseudomonas aeruginosa induced greater release of CXCL8 than Gram-positive bacteria. However, Gram-negative bacteria did not affect epithelial barrier function directly, but prevented disruption induced by Gram-positive bacteria. These effects of Gram-negative bacteria on barrier function were mimicked by FK565, an agonist of the nucleotide-binding oligomerization domain 1 (NOD1) receptor, but not by the Toll-like receptor (TLR) 4 agonist bacterial lipopolysaccharide. Neither the Gram-negative bacteria nor FK565 blocked CXCL8 release.
CONCLUSIONS: These data show differential functional responses induced by Gram-negative and Gram-positive bacteria in human lung epithelial cells. The NOD1 receptors may have a role in preventing disruption of the epithelial barrier in lung, during inflammatory states.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18536738      PMCID: PMC2439843          DOI: 10.1038/bjp.2008.139

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers.

Authors:  Dodanim Talavera; Aida M Castillo; M C Dominguez; Alejandro Escobar Gutierrez; Isaura Meza
Journal:  J Gen Virol       Date:  2004-07       Impact factor: 3.891

2.  Microbial DNA induces a host defense reaction of human respiratory epithelial cells.

Authors:  Juliane Platz; Christoph Beisswenger; Alexander Dalpke; Rembert Koczulla; Olaf Pinkenburg; Claus Vogelmeier; Robert Bals
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

3.  Effect of anticancer drugs on the release of interferon gamma in vitro.

Authors:  K Ahmed; P H van der Meide; J L Turk
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Specific C-terminal cleavage and inactivation of interleukin-8 by invasive disease isolates of Streptococcus pyogenes.

Authors:  Robert J Edwards; Graham W Taylor; Melissa Ferguson; Stephen Murray; Nigel Rendell; Amanda Wrigley; Zhonghu Bai; Joseph Boyle; Simon J Finney; Angus Jones; Hugh H Russell; Claire Turner; Jonathan Cohen; Lee Faulkner; Shiranee Sriskandan
Journal:  J Infect Dis       Date:  2005-07-18       Impact factor: 5.226

5.  TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.

Authors:  Catherine M Greene; Tomás P Carroll; Stephen G J Smith; Clifford C Taggart; James Devaney; Siobhan Griffin; Shane J O'neill; Noel G McElvaney
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

6.  Cyclooxygenase-2 regulates granulocyte-macrophage colony-stimulating factor, but not interleukin-8, production by human vascular cells: role of cAMP.

Authors:  S J Stanford; J R Pepper; J A Mitchell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

7.  CD36 is a sensor of diacylglycerides.

Authors:  Kasper Hoebe; Philippe Georgel; Sophie Rutschmann; Xin Du; Suzanne Mudd; Karine Crozat; Sosathya Sovath; Louis Shamel; Thomas Hartung; Ulrich Zähringer; Bruce Beutler
Journal:  Nature       Date:  2005-02-03       Impact factor: 49.962

8.  Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle.

Authors:  Rosario Jimenez; Elizabeth Belcher; Shiranee Sriskandan; Ruth Lucas; Shaun McMaster; Ivana Vojnovic; Timothy D Warner; Jane A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-08       Impact factor: 11.205

Review 9.  Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease.

Authors:  Jane A Mitchell; Mark J Paul-Clark; Graham W Clarke; Shaun K McMaster; Neil Cartwright
Journal:  J Endocrinol       Date:  2007-06       Impact factor: 4.286

10.  Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells.

Authors:  Lynne Armstrong; Andrew R L Medford; Kay M Uppington; John Robertson; Ian R Witherden; Teresa D Tetley; Ann B Millar
Journal:  Am J Respir Cell Mol Biol       Date:  2004-03-25       Impact factor: 6.914

View more
  8 in total

Review 1.  Immunopathogenesis of Staphylococcus aureus pulmonary infection.

Authors:  Dane Parker; Alice Prince
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

Review 2.  TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer.

Authors:  Aina Martín-Medina; Noemi Cerón-Pisa; Esther Martinez-Font; Hanaa Shafiek; Antònia Obrador-Hevia; Jaume Sauleda; Amanda Iglesias
Journal:  Int J Mol Sci       Date:  2022-06-11       Impact factor: 6.208

3.  Toll-Like Receptor 4 Is Essential for the Expression of Sphingosine-1-Phosphate-Dependent Asthma-Like Disease in Mice.

Authors:  Fiorentina Roviezzo; Rosalinda Sorrentino; Michela Terlizzi; Maria Antonietta Riemma; Valentina Mattera Iacono; Antonietta Rossi; Giuseppe Spaziano; Aldo Pinto; Bruno D'Agostino; Giuseppe Cirino
Journal:  Front Immunol       Date:  2017-10-18       Impact factor: 7.561

Review 4.  TLRs in pulmonary diseases.

Authors:  Shweta Arora; Shaniya Ahmad; Rasha Irshad; Yamini Goyal; Sahar Rafat; Neha Siddiqui; Kapil Dev; Mohammad Husain; Shakir Ali; Anant Mohan; Mansoor Ali Syed
Journal:  Life Sci       Date:  2019-07-20       Impact factor: 5.037

5.  Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.

Authors:  Cristina Cigana; Laura Curcurù; Maria Rosaria Leone; Teresa Ieranò; Nicola Ivan Lorè; Irene Bianconi; Alba Silipo; Flora Cozzolino; Rosa Lanzetta; Antonio Molinaro; Maria Lina Bernardini; Alessandra Bragonzi
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

Review 6.  The role of airway epithelial cells in response to mycobacteria infection.

Authors:  Yong Li; Yujiong Wang; Xiaoming Liu
Journal:  Clin Dev Immunol       Date:  2012-04-18

7.  Comparison of innate immune agonists for induction of tracheal antimicrobial peptide gene expression in tracheal epithelial cells of cattle.

Authors:  Lesley Berghuis; Khaled Taha Abdelaziz; Jodi Bierworth; Leanna Wyer; Gabriella Jacob; Niel A Karrow; Shayan Sharif; Mary Ellen Clark; Jeff L Caswell
Journal:  Vet Res       Date:  2014-10-12       Impact factor: 3.683

Review 8.  Cross-Talk Between Alveolar Macrophages and Lung Epithelial Cells is Essential to Maintain Lung Homeostasis.

Authors:  Elyse Y Bissonnette; Jean-François Lauzon-Joset; Jason S Debley; Steven F Ziegler
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.